Concepedia

Publication | Closed Access

Low‐dose rituximab in adult patients with primary immune thrombocytopenia

124

Citations

16

References

2010

Year

Abstract

Low-dose rituximab is active in ITP but has moderate long-term effect. A comparative study with standard dose is warranted.

References

YearCitations

Page 1